Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists [PMID: 42420795] Laboratory literature summary: Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists
Changing the dose for special conditions needs careful thought and a doctors advice
Joannas work focuses on identifying microbiota- and gene-based biomarkers to better understand and support individuals affected by depression, MASLD, metabolic dysfunction, and emotional eating
Oral glutathione supplements may, from time to time, cause nausea, bloating, diarrhea, or stomach discomfort, especially when taken on an empty stomach or when taken in excess of the recommended dose
Labs monitor copper and ceruloplasmin to ensure safety